Stay updated on Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page.

Latest updates to the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedA banner was added announcing that NIH websites are transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page remains a 403 error page.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page now renders a 403 Forbidden error page, replacing the study record content with a standard error view. This change obscures the core study details and navigation, preventing access to the trial information.SummaryDifference19%

- Check44 days agoChange DetectedThe study record now shows termination of GEN1046 development with a sponsor note that the decision was not due to safety concerns; recruitment site details and statuses have been updated, including removal or alteration of certain locations.SummaryDifference0.4%

- Check51 days agoChange DetectedIsrael study locations were updated: Tel Litwinsky, Israel, 52621 was removed and Qiryat Krinitzi, Israel, 52621 was added.SummaryDifference0.1%

Stay in the know with updates to Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Evaluation of Novel Treatment in Solid Tumors Clinical Trial page.